You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
康芝藥業(300086.SZ):在研產品兒童氫溴酸右美沙芬膜目前正在臨牀研究階段
格隆匯 11-09 14:18

格隆匯11月9日丨康芝藥業(300086.SZ)在投資者互動平台表示,公司在研產品兒童氫溴酸右美沙芬膜目前正在臨牀研究階段,正在按照預計的進度進行推進。由於醫藥產品具有高科技、高風險、高附加值的特點,臨牀試驗、審評和審批的結果以及時間都具有一定的不確定性。後續如有重大進展,公司將根據《上市公司信息披露管理辦法》等相關規定,及時履行信息披露義務。 兒童氫溴酸右美沙芬膜是一款無苦味鎮咳類口腔速溶膜劑,其採用先進掩味技術,明顯改善其口感,患者順應性好;給藥方便,不需飲水即可服用,放在舌上即溶,且黏附後不易吐出,劑量準確,尤其適合吞嚥困難的老人和兒童。 公司擁有"具有微孔的海綿狀的氫溴酸右美沙芬膜劑及其製備方法"發明專利,同時不斷提高膜劑技術等藥製劑技術方面的研發水平,探索性研究膜劑技術在其他產品(包括成人及兒童產品)上的應用,以確保公司藥品的口感、順應性及其他技術指標在同類產品中保持優勢。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account